The role of calcium phosphate in the development of Randall's plaques

Urological Research

Volumn 41, Issue 5, 2013, Pages 369-377

  Tiselius, Hans Göran ^a  

^a Intervention and Technology ^*  (Sweden)

Author keywords

Amorphous calcium phosphate; Calcium oxalate; Calcium phosphate; Crystal cell interaction; Crystallization; Hydroxyapatite; Inhibitors; Internalization; Nephron; Promoters; Randall's plaques; Renal papilla

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; APATITE; CALCIUM ION; CALCIUM PHOSPHATE DIBASIC; CARBONIC ACID; CITRATE POTASSIUM; DIURETIC AGENT; HYDROXYAPATITE; PHOSPHOLIPID;

CALCIUM OXALATE STONE; HUMAN; KIDNEY CALCIFICATION; KIDNEY COLLECTING TUBULE; KIDNEY INTERSTITIUM; PRIORITY JOURNAL; RANDALL PLAQUE; RECURRENT DISEASE; REVIEW; STONE FORMATION; ACIDIFICATION; BASEMENT MEMBRANE; CHEMICAL COMPOSITION; COFFEE; CRYSTALLIZATION; INFLAMMATION; INTERNALIZATION; KIDNEY PAPILLA; MACROMOLECULE; MEAL; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PRECIPITATION; URINE PH; UROLITHIASIS;

CALCIUM OXALATE; CALCIUM PHOSPHATES; CRYSTALLIZATION; HUMANS; KIDNEY CALCULI; KIDNEY MEDULLA; KIDNEY TUBULES; MODELS, BIOLOGICAL;

EID: 84892365752     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-013-0602-7     Document Type: Review

References (71)

1. Randall A (1940) Papillary pathology as a precursor of primary renal calculus. J Urol 44:580
2. Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stones formation. Urol Res 38: 147-160
3. Evan AP, Lingeman J, Coe FL, Worcester E (2006) Randall's plaque: Pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69:1313-1318
4. Tiselius HG (2011) A hypothesis of calcium stone formation: An interpretation of stone research during the past decades. Urol Res 39:231-243
5. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607-616
6. Miller N, Williams JCJ, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Handa SE, Lingeman JE (2010) In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int 105:242-245
7. Daudon M, Jungers P (2012) Stone composition and morphology: A window on etiology. In: Talati JJ, Tiselius HG, Albala DM, Ye Z (eds) Urolithiasis Basic science and clinical practice. Springer, London, pp 113-140
8. Smith LH, Werness PG (1983) Hydroxyapatite-the forgotten crystal in calcium urolithiasis. Trans Amer Clin Chem Assoc 95:183-190
9. Tiselius HG, Larsson L (1993) Calcium phosphate-an important crystal phase in patients with recurrent calcium stone formation? Urol Res 21:175-180
10. Ohman S, Larsson L (1992) Evidence for Randall's plaques to be the origin of primary renal stones. Med Hypothesis 39:360-363
11. Ohman S, Larsson L, Tiselius HG (1992) Clinical significance of phosphate in calcium oxalate renal stones. Ann Clin Biochem 29:59-63
12. Finlayson B, Reid F (1978) The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442-448
13. Tiselius HG (1996) Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney Stones: Medical and Surgical Management. Lippincott-Raven Publishers, Philadelphia, pp 33-64
14. Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1999) Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: Influence of hydroxyapatite seed crystals and urinary macromolecules. Urol Res 27:417-425
15. Borghi L, Meschi T, Guerra A, Bergamaschi E, Mutti A, Novarini A (1995) Effect of urinary acromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Clin Chim Acta 239:1-11
16. Carvalho M, Mulinari R, Nakagawa Y (2002) Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization. Braz J Med Biol Res 35:1165-1172
17. Gorski JP (1992) Acidic phosphoproteins from bone matrix: A structural rationalization of heir role in biomineralization. Calif Tissue Int 50:391-396
18. Kok D, Schell-Feith E (1999) Risk factors for crystallisation in the nephron: The role of renal development. J Am Soc Nephrol 10:S364-S370
19. Maslamani S, Glenton PA, Khan SR (2000) Changes in urine macromolecular composition during processing. J Urol 164:230-236
20. Fasano JM, Khan S (2001) Intratubular crystallisation of calcium oxalate in the presence of membrane vesicles: An in vitro study. Kidney Int 59:169-178
21. Fernandez-Conde M, Alcover J, Barastegui C, Carretero P (1995) Calculi of papillary origin. Ann Urol (Paris) 29:35135-35136
22. Grases F, March JG, Conte A, Costa-Bautzá A (1993) New aspects on the composition, structure and origin of calcium oxalate monohydate calculi. Eur Urol 24:38138-38139
23. Prien EL (1975) The riddle of Randall's plaques. J Urol 114: 500-507
24. Cifuentes Delatte L, Minon Cifuentes J, Medina JA (1996) Randall and his plaque. Urology 48:343-346
25. Koutsoukos PG, Nancollas GH (1981) Crystal growth of calcium phosphates-epitaxial considerations. J Cryst Growth 53:10-19
26. Koutsoukos PG, Sheehan ME, Nancollas GH (1981) Epitaxial considerations in urinary stone formation. II. The oxalate-phosphate system. Invest Urol 18:358-363
27. Nancollas GH (1983) Crystallization theory relating to urinary stone formation. World J Urol 1:131-137
28. Evan AP (2010) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25:831-841
29. Cifuentes Delatte L, Minon-Cifuentes JL, Medina JA (1985) Papillary stones: Calcified tubules in renal plaques. J Urol 133:490-494
30. Evan AP, Unvin RJ, Williams JJC (2011) Renal stone disease: A commentary on the nature and significance of Randall's plaque. Nephron Physiol 119:49-53
31. Fan J, Chandoke PS (1999) Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique. J Urol 161:1685-1688
32. Tiselius HG (2011) Chemolytic treatment of patients with urinary tract stones. In: Rao PN, Preminger GM, Kavanagh JP (eds) Urinary tract stone disease. Springer-Verlag, London, pp 627-637
33. Hojgaard I, Tiselius HG (1999) Crystallisation in the nehron. Urol Res 27:397-403
34. Tiselius HG, Lindback B, Fornander AM, Nilsson MA (2009) Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation. Urol Res 37:181-192
35. Tiselius HG, Hojgaard I (1999) Some aspects of the intratubular precipitation of calcium salts. J Am Soc Nephrol 10:S371-S375
36. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec 290:131513-131523
37. Mandeville JA, Gnessin E, Lingeman JE (2012) Current understanding of the role of Randall's plaque. In: Talati JJ, Tiselius HG, Albala DM, Ye Z (eds) Urolithiasis Basic science and clinical practice. Springer-Verlag, London, pp 209-218
38. Baumann JM, Affolter B, Caprez U, Henze U, Lauper D, Maier F (2001) Hydroxyapatite induction and secondary aggregation, two important processes in calcium stone formation. Urol Res 29: 417-422
39. Hess B (1994) Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 20:393-398
40. Adamthwaite DN (1983) Urinary particulate activity in urinary calculus disease. Br J Urol 55:95-99
41. Crassweller PO, Brandes L, Katrizoglou A, Oreopoulos DG (1979) Studies on crystalluria in recurrent calcium lithiasis. Can J Surg 22:527-529
42. Robertson WG, Peacock M (1972) Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers. Clin Sci 43:499-506
43. Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Cryst Growth 53:166-181
44. Tiselius HG, Lindback B, Fornander AM, Nilsson MA (2009) Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation. Urol Res 37:181-192
45. Coe FL, Evan AP, Lingeman JE, Worcester EM (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239-247
46. Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847-854
47. Asplin J, DeGanello S, Nakgawa YN, Coe F (1991) Evidence for calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604-F613
48. Kok DJ, Schell-Feith EA (1999) Risk factors for crystallisation in the nephron: The role of renal development. J Am Soc Nephrol 10:S364-S370
49. Luptak J, Bek-Jensen H, Fornander AM, Hojgaard I, Nilsson MA, Tiselius HG (1994) Crystallization of calcium oxalate and calcium phosphate at supersaturation levels corresponding to those in different parts of the nephron. Scanning Microsc 8:47-62
50. Asplin JR, Mandel NS, Coe FL (1996) Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604-F613
51. DeGanello S, Asplin J, Coe FL (1990) Evidence that the fluid in the thin segment of the loop of Henle normally is supersaturated and forms poorly crystallized hydroxyapatite that can initiate renal stones. (Abstract). Kidney Int 37:472
52. Hering F, Lueoend G, Briellmann T, Seiler H, Guggenheim H, Rutishauser G (1988) Stone formation in the human kidney. In: Walker VR, Sutton RL, Cameron B, Pak CYC, Roberston WG (eds) Urolithiasis. Plenum Press, New York, pp 73-74
53. Resnick MI, Boyce WH (1978) Spherical calcium bodies in stone-forming urine. Invest Urol 15:449-451
54. Amos FA, Dai L, Kumar R, Khan SR, Gower LB (2009) Mechanism of formation of concentrically laminated spherules: Implication to Randall's plaque and stone formation. Urol Res 37:11-17
55. Khan SR, Glenton PA, Backov R, Talham DR (2002) Presence of lipids in urine, crystals and stones: Implications for the formation of kidney stones. Kidney Int 62:2062-2072
56. Achilles W (1997) In vitro crystallization systems for the study of urinary stone formation. World J Urol 15(244-51):244-251
57. Achilles W, Jockel U, Schaper A, Ulshofer B, Riedmiller H (1994) Formation of urinary stones in vitro: Growth of calcium oxalate on spherulites of calcium phosphate in gel. In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum Press, New York, pp 161-165
58. Ciftcioglu N, Vejdani K, Lee O, Methew G, Aho K, Kajander EO, McKay DS, Jones JA, Stoller ML (2008) Association between Randall's plaque and calcifying nanoparticles. Int J Nanomedicine 3:105-115
59. Khan SR (2004) Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 98: E55-e60
60. Khan SR (2012) Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res 40:95-112
61. Joshi S, Peck AB, KhanSR (2013)NADPHoxidase as a therapeutic target for oxalate induced injury in kidneys. Oxid Med Cell Longev 2013:462361. doi:10.1155/2013/462361. Epub 2013 Jun 6
62. Khan S, Kok D (2004) Modulators of urinary stone formation. Front Biosci 9:1450-1482
63. Kok DJ (1996) Crystallization and stone formation inside the nephron. Scanning Microsc 10:471-486
64. Kok DJ, Khan SR (1995) Chances for free or fixed particle mechanism. In: Rao PN, Kavanagh JP, Tiselius HG (eds) Urolithiasis Consensus and Controversies. Lithtripter Unit, Withington Hospital, Manchester, pp 431-432
65. Lieske JC, Walsh-Reitz MM, Toback FG (1992) Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol (Renal Electrolyte Physiol) 262:F622-F630
66. Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL (2008) Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stoneforming patients. Am J Physiol Renal Physiol 295:F1286-F1294
67. Coe FL, Evan A, Worcester E (2011) Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol 6:2083-2092
68. Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL (2003) Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int 64:2150-2154
69. Lieske JC, Coe FL (1996) Urinary inhibitors and renal stone formation. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones Medical and surgical management. Lippincott Raven Publishers, Hagerstown, pp 65-113
70. Fuselier HA, Moore K, Lindberg J, Husserl FE, Cole FE, Kok DJ, Whitehead D, Galliano DJ, Erwin DT (1998) Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers. Urology 52:988-994
71. Tiselius HG (1997) Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule. Urol Res 25:153-159